Assessment and Prioritization of Attractive IO Targets

Oncology

A global pharma company needed to make strategic choices to acquire their next IO targets. SmartAnalyst adopted the following approach to accomplish the objectives: Conducted secondary research to map the IO universe and pre-screened the long list …

Click here to read our case study

Identification of External Opportunities to Strengthen Client’s Portfolio in Emerging Markets

Specialty Therapeutics

A global pharmaceutical company wanted to strengthen its portfolio in emerging markets and engaged SmartAnalyst to generate asset opportunities available for potential partnering, develop a list of attractive indications within the GI, Oncology, and Diabetes therapy areas, identify external opportunity set within attractive indications…

Click here to read our case study

Assessing commercial potential of an asset in Tourette’s Syndrome

Rare Diseases

A leading pharmaceutical company wanted to assess the commercial opportunity for an asset for Tourette’s Syndrome (TS). SmartAnalyst was engaged to estimate: Revenue forecast and NPV for base and ideal TPP…

Click here to read our case study

Assessing commercial potential of an asset in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Other Therapeutic Areas

A global bio-pharmaceutical company wanted to make informed clinical and commercial decisions to optimize commercial value for its asset (Product X) in development for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in the US, EU5, and Japan. The objective was to identify market and product-related drivers likely to impact the clinical development strategy and commercial potential …

Click here to read our case study